Paratek Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $160.3M | $130.2M | $7.9M | $1.6M | $10,000 | $18,000 |
| Operating income | −$46.2M | −$41.1M | −$23.6M | −$33.3M | −$26.7M | −$26.8M |
| Net income | −$63.6M | −$59.1M | −$27.6M | −$35.6M | −$27.8M | −$27.7M |
| Total assets | $172.5M | $183.9M | $176.9M | $251.1M | $300.2M | $163.7M |
| Total liabilities | $343.6M | $311.7M | $279.1M | $290.7M | $252.6M | $81.2M |
| Equity | −$171.0M | −$127.8M | −$102.3M | −$39.6M | $47.6M | $82.5M |
| EPS (diluted) | $-1.17 | $-1.22 | — | — | — | — |
| Shares out. | 52.4M | 46.9M | 42.2M | 32.4M | 31.4M | 24.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −28.8%
- Net margin
- −39.7%
- Return on equity
- 37.2%
- Return on assets
- −36.8%
- Return on capital (ROCE)
- −34.2%
- Liabilities / assets
- 199.1%
- Debt / equity
- —
- Book value / share
- $-3.27
- Revenue growth (YoY)
- 23.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -16.12distress
- Accruals / assets
- 1.5%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · New financial obligation · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureSep 21, 2023
- Shareholder vote · Other material eventSep 18, 2023
- Other material eventSep 11, 2023
- Shareholder voteJul 11, 2023
- Entered a material agreement · Director / officer change · Other material eventJun 7, 2023
- Amended charter or bylawsMar 14, 2023
- Shareholder voteJun 9, 2022
- Entered a material agreement · Regulation FD disclosureSep 27, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GOct 2, 2023
- EFFECTSep 25, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- 4FORM 4 SUBMISSIONSep 21, 2023
- SC 13E3/ASep 21, 2023
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.